21 Invest has recently announced the launch of its first specialized fund, 21 Invest Healthcare, which aims to capitalize on the growing healthcare sector.
The fund will invest in Italian and European companies that show high growth potential, particularly those focused on innovative products and services that improve the wellbeing of people and animals.
The fund's areas of focus include healthcare, wellness, nutraceuticals, advanced cosmetics, and veterinary services.
Alessandro Benetton, Chairman of 21 Invest, emphasized the importance of the healthcare industry and the increasing interest from institutional and private investors.
Notable supporters of the fund include Fondo Italiano and the European Investment Fund.
The launch of 21 Invest Healthcare aligns with the ongoing trends in the medical and pharmaceutical sectors and reflects the group's experience in these fields.
The fund also prioritizes sustainability and aims to combine financial performance with social and environmental impacts.
By targeting companies that prioritize innovative solutions in healthcare, 21 Invest Healthcare aims to be at the forefront of a sector that is expected to grow significantly.
The healthcare sector has been in high demand, especially in light of recent global health challenges, and investors recognize the potential of healthcare innovations.
21 Invest's history of successful investments in the medical field positions it well to support the next generation of healthcare innovators.
The fund aims to create a lasting impact in the healthcare sector by fostering a portfolio that includes companies committed to innovation and sustainability.
The launch of 21 Invest Healthcare represents a significant step for the investment group as it enters the complex healthcare sector with a focus on growth, sustainability, and innovation.